Metabolism Society
  your resource for truth in nutritional  science


Globe
join today
           
Diabetes Obesity Low Carb Diet About Fat Learn Professionals Learn Consumer Conferences Locate Freebies Research Membership Membership
         
   
If you have a specific question concerning proper nutrition –
Ask Valerie!

Name:

City      State




Answers to your questions (but not personal identity) are displayed on this website.

All answers are for informational purposes only. The content is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, dental professional, or qualified health provider with any questions you may have regarding a medical condition. Questions:If you have a specific question concerning proper nutrition – Ask Valerie! Answers to your questions (but not personal identity) are displayed on this website. All answers are for informational purposes only. The content is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, dental professional, or qualified health provider with any questions you may have regarding a medical condition.

Questions:

Would it speed up weight loss if I take Alli along with being on a low carb diet?

I do not recommend taking Alli. If you are not getting the results you want take the time to determine why this is happening. If it is emotional psychological or physical, you will need to correct the underlying problem to get the results you seek. Alli will act like a band-aid. It will “cover-up” the problem and you may see weight loss but it is not a long term solution.

You may be able to get my book from the library and use the check off list to help identify supplements and other tips that may be helpful for long term success.

From: FDA MedWatch
Date: Mon, 24 Aug 2009 16:13:51 -0500 (CDT)
Subject: MedWatch - Orlistat (marketed as Alli and Xenical): FDA reviewing reports of serious liver injury, including liver failure

Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review Audience: Endocrinological healthcare professionals, patients

FDA notified healthcare professionals and patients that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat. Orlistat is marketed in the United States as a prescription product, Xenical, and as an over-the-counter (OTC) product, Alli. Between 1999 and October 2008, 32 reports of serious liver injury, including 6 cases of liver failure, in patients using orlistat were submitted to FDA’s Adverse Event Reporting System. The most commonly reported adverse events described in the 32 reports of serious liver injury were jaundice, weakness, and abdominal pain. FDA is reviewing other data on suspected cases of liver injury submitted by the manufacturers of orlistat, analysis of these data is ongoing and no definite association between liver injury and orlistat has been established at this time. FDA is not advising healthcare professionals to change their prescribing practices with orlistat. Consumers currently taking Xenical should continue to take it as prescribed and those using over-the-counter Alli should continue to use the product as directed.

FDA urges both healthcare professionals and consumers to report side effects from the use of orlistat (Alli and Xenical) to FDA's MedWatch Adverse Event Reporting program.

Read the complete MedWatch Safety summary, including links to the Early Communication and FDA News Release, at:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/
SafetyAlertsforHumanMedicalProducts/ucm180025.htm
Stubborn Fat Fix Book
















© 2008 Nutrition & Metabolism Society                                          Website built by Jeff Marek